[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Over-The-Counter (OTC) Drugs Market Report 2017

August 2017 | 111 pages | ID: U2D977BDEBAEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Over-The-Counter (OTC) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Over-The-Counter (OTC) Drugs in these regions, from 2012 to 2022 (forecast).
United States Over-The-Counter (OTC) Drugs market competition by top manufacturers/players, with Over-The-Counter (OTC) Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bayer
  • Boehringer Ingelheim
  • GSK
  • Novartis
  • Pfizer
  • PGT healthcare
  • Sanofi
  • Teva Pharmaceuticals
  • Takeda
  • Cipla
  • Sun Pharmaceutical Industries
  • Glenmark
  • Innovus Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Cold and Flu Products
  • Analgesics
  • Dermatological Products
  • Gastrointestinal Products
  • Vitamin
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Over-The-Counter (OTC) Drugs for each application, including
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Over-The-Counter (OTC) Drugs Market Report 2017

1 OVER-THE-COUNTER (OTC) DRUGS OVERVIEW

1.1 Product Overview and Scope of Over-The-Counter (OTC) Drugs
1.2 Classification of Over-The-Counter (OTC) Drugs by Product Category
  1.2.1 United States Over-The-Counter (OTC) Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Over-The-Counter (OTC) Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Cold and Flu Products
  1.2.4 Analgesics
  1.2.5 Dermatological Products
  1.2.6 Gastrointestinal Products
  1.2.7 Vitamin
  1.2.8 Other
1.3 United States Over-The-Counter (OTC) Drugs Market by Application/End Users
  1.3.1 United States Over-The-Counter (OTC) Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 United States Over-The-Counter (OTC) Drugs Market by Region
  1.4.1 United States Over-The-Counter (OTC) Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Over-The-Counter (OTC) Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Over-The-Counter (OTC) Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Over-The-Counter (OTC) Drugs Status and Prospect (2012-2022)
  1.4.5 New England Over-The-Counter (OTC) Drugs Status and Prospect (2012-2022)
  1.4.6 The South Over-The-Counter (OTC) Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Over-The-Counter (OTC) Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Over-The-Counter (OTC) Drugs (2012-2022)
  1.5.1 United States Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES OVER-THE-COUNTER (OTC) DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Over-The-Counter (OTC) Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Over-The-Counter (OTC) Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Over-The-Counter (OTC) Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Over-The-Counter (OTC) Drugs Market Competitive Situation and Trends
  2.4.1 United States Over-The-Counter (OTC) Drugs Market Concentration Rate
  2.4.2 United States Over-The-Counter (OTC) Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Over-The-Counter (OTC) Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OVER-THE-COUNTER (OTC) DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Over-The-Counter (OTC) Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Over-The-Counter (OTC) Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Over-The-Counter (OTC) Drugs Price by Region (2012-2017)

4 UNITED STATES OVER-THE-COUNTER (OTC) DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Over-The-Counter (OTC) Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Over-The-Counter (OTC) Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Over-The-Counter (OTC) Drugs Price by Type (2012-2017)
4.4 United States Over-The-Counter (OTC) Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OVER-THE-COUNTER (OTC) DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Over-The-Counter (OTC) Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Over-The-Counter (OTC) Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OVER-THE-COUNTER (OTC) DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bayer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim
  6.2.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 PGT healthcare
  6.6.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi
  6.7.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceuticals
  6.8.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Takeda
  6.9.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Takeda Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Cipla
  6.10.2 Over-The-Counter (OTC) Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Cipla Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Sun Pharmaceutical Industries
6.12 Glenmark
6.13 Innovus Pharmaceuticals

7 OVER-THE-COUNTER (OTC) DRUGS MANUFACTURING COST ANALYSIS

7.1 Over-The-Counter (OTC) Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Over-The-Counter (OTC) Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Over-The-Counter (OTC) Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Over-The-Counter (OTC) Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OVER-THE-COUNTER (OTC) DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Over-The-Counter (OTC) Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Over-The-Counter (OTC) Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Over-The-Counter (OTC) Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Over-The-Counter (OTC) Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Over-The-Counter (OTC) Drugs
Figure United States Over-The-Counter (OTC) Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Over-The-Counter (OTC) Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Cold and Flu Products Product Picture
Figure Analgesics Product Picture
Figure Dermatological Products Product Picture
Figure Gastrointestinal Products Product Picture
Figure Vitamin Product Picture
Figure Other Product Picture
Figure United States Over-The-Counter (OTC) Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Over-The-Counter (OTC) Drugs by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure United States Over-The-Counter (OTC) Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Over-The-Counter (OTC) Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Over-The-Counter (OTC) Drugs Sales Share by Players/Suppliers
Figure 2017 United States Over-The-Counter (OTC) Drugs Sales Share by Players/Suppliers
Figure United States Over-The-Counter (OTC) Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Over-The-Counter (OTC) Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Over-The-Counter (OTC) Drugs Revenue Share by Players/Suppliers
Table United States Market Over-The-Counter (OTC) Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Over-The-Counter (OTC) Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Over-The-Counter (OTC) Drugs Market Share of Top 3 Players/Suppliers
Figure United States Over-The-Counter (OTC) Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Over-The-Counter (OTC) Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Over-The-Counter (OTC) Drugs Product Category
Table United States Over-The-Counter (OTC) Drugs Sales (K Units) by Region (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Sales Share by Region (2012-2017)
Figure United States Over-The-Counter (OTC) Drugs Sales Share by Region (2012-2017)
Figure United States Over-The-Counter (OTC) Drugs Sales Market Share by Region in 2016
Table United States Over-The-Counter (OTC) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Revenue Share by Region (2012-2017)
Figure United States Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2012-2017)
Figure United States Over-The-Counter (OTC) Drugs Revenue Market Share by Region in 2016
Table United States Over-The-Counter (OTC) Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Sales Share by Type (2012-2017)
Figure United States Over-The-Counter (OTC) Drugs Sales Share by Type (2012-2017)
Figure United States Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2016
Table United States Over-The-Counter (OTC) Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Over-The-Counter (OTC) Drugs by Type (2012-2017)
Figure Revenue Market Share of Over-The-Counter (OTC) Drugs by Type in 2016
Table United States Over-The-Counter (OTC) Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Over-The-Counter (OTC) Drugs Sales Growth Rate by Type (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Sales (K Units) by Application (2012-2017)
Table United States Over-The-Counter (OTC) Drugs Sales Market Share by Application (2012-2017)
Figure United States Over-The-Counter (OTC) Drugs Sales Market Share by Application (2012-2017)
Figure United States Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2016
Table United States Over-The-Counter (OTC) Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Over-The-Counter (OTC) Drugs Sales Growth Rate by Application (2012-2017)
Table Bayer Basic Information List
Table Bayer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Over-The-Counter (OTC) Drugs Sales Growth Rate (2012-2017)
Figure Bayer Over-The-Counter (OTC) Drugs Sales Market Share in United States (2012-2017)
Figure Bayer Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Over-The-Counter (OTC) Drugs Sales Growth Rate (2012-2017)
Figure GSK Over-The-Counter (OTC) Drugs Sales Market Share in United States (2012-2017)
Figure GSK Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Over-The-Counter (OTC) Drugs Sales Growth Rate (2012-2017)
Figure Novartis Over-The-Counter (OTC) Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Over-The-Counter (OTC) Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Over-The-Counter (OTC) Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2012-2017)
Table PGT healthcare Basic Information List
Table PGT healthcare Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure PGT healthcare Over-The-Counter (OTC) Drugs Sales Growth Rate (2012-2017)
Figure PGT healthcare Over-The-Counter (OTC) Drugs Sales Market Share in United States (2012-2017)
Figure PGT healthcare Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Over-The-Counter (OTC) Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Over-The-Counter (OTC) Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceuticals Basic Information List
Table Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales Growth Rate (2012-2017)
Figure Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2012-2017)
Table Takeda Basic Information List
Table Takeda Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Over-The-Counter (OTC) Drugs Sales Growth Rate (2012-2017)
Figure Takeda Over-The-Counter (OTC) Drugs Sales Market Share in United States (2012-2017)
Figure Takeda Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2012-2017)
Table Cipla Basic Information List
Table Cipla Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cipla Over-The-Counter (OTC) Drugs Sales Growth Rate (2012-2017)
Figure Cipla Over-The-Counter (OTC) Drugs Sales Market Share in United States (2012-2017)
Figure Cipla Over-The-Counter (OTC) Drugs Revenue Market Share in United States (2012-2017)
Table Sun Pharmaceutical Industries Basic Information List
Table Glenmark Basic Information List
Table Innovus Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Over-The-Counter (OTC) Drugs
Figure Manufacturing Process Analysis of Over-The-Counter (OTC) Drugs
Figure Over-The-Counter (OTC) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Over-The-Counter (OTC) Drugs Major Players/Suppliers in 2016
Table Major Buyers of Over-The-Counter (OTC) Drugs
Table Distributors/Traders List
Figure United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Over-The-Counter (OTC) Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Over-The-Counter (OTC) Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Over-The-Counter (OTC) Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Over-The-Counter (OTC) Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Over-The-Counter (OTC) Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications